[{"id":"e8e3fb37-f6eb-4988-8fde-31e6fed613d2","acronym":"","url":"https://clinicaltrials.gov/study/NCT06008483","created_at":"2023-08-23T15:11:16.577Z","updated_at":"2024-07-02T16:35:39.287Z","phase":"Phase 1","brief_title":"A Dose Finding Study to Treat Bone Tumor(s)","source_id_and_acronym":"NCT06008483","lead_sponsor":"QSAM Therapeutics, Inc.","biomarkers":" CD34","pipe":"","alterations":" ","tags":["CD34"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CycloSam (samarium-153 DOTMP)"],"overall_status":"Recruiting","enrollment":" Enrollment 17","initiation":"Initiation: 04/05/2022","start_date":" 04/05/2022","primary_txt":" Primary completion: 04/05/2024","primary_completion_date":" 04/05/2024","study_txt":" Completion: 11/01/2024","study_completion_date":" 11/01/2024","last_update_posted":"2023-08-23"}]